Formulated for glaucoma to manage intraocular pressure and support vision preservation.
Mechanism of Action
Latanoprost is a prostanoid selective FP receptor agonist. It reduces intraocular pressure by increasing the uveoscleral outflow of aqueous humor from the eye.
Route of Administration
Ophthalmic
Onset Time
3–4 hours
Duration
24 hours
Contraindications
Hypersensitivity to latanoprost, Active intraocular inflammation
Severe Adverse Events
Macular edema, Uveitis, Anaphylaxis — requires immediate medical attention
Common Side Effects
Blurred vision, Burning, Eye redness
Uncommon Side Effects
Iris color change, Eyelash growth, Foreign body sensation
Drug Interactions
Alcohol, Bimatoprost, Timolol
Pregnancy Safety Warnings
FDA Category C: Use only if benefits outweigh risks. Breastfeeding: Excreted in milk; monitor infant.
Age Restrictions
Safety and efficacy established in pediatric patients of all ages.
Storage Guidelines
Store unopened bottles in refrigerator; once opened, store at room temperature for up to 6 weeks.
Information related to Xalatan 0.005% is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
